An outstanding collaboration
This growth leads to an expansion of Novadip’s research and development goals – and an expected increase in hiring.
Jean-François Pollet, CEO and co-founder of Novadip said « The proceeds will be used to advance clinical development of Creost and realize its full potential as a first-in-class medicinal product with broad applicability in bone reconstruction. »
We are delighted to announce that PaHRtners starts a strategic collaboration with Novadip Biosciences, a leader in first-in-class treatments for bone reconstruction. We are actively looking for candidates eager to join this high-potential innovative company. All jobs are based in the Brussels area (Louvain-la-Neuve), in an English-speaking work environment.
PaHRtners is already searching for a Director Clinical Development who will be responsible for the company’s novel regenerative medicines development and registration:
Director Clinical Development
As a Director Clinical Development, you are responsible for the company’s novel regenerative medicines development and registration. Reporting to the CEO, you strategically lead the clinical operations in a matrix organisation. With regards to resources and results, you efficiently manage the clinical team.
To keep up to date with HR news, job vacancies and other topics related to the life sciences and industry sectors, join us onLinkedIn or visit the rest of our website!
